Evidence map›Paper›PMID 11094086›Full record

ArticleMolecular and cellular biology2000

Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.

M Li, X Wang, M K Meintzer, T Laessig, M J Birnbaum, K A Heidenreich

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 362 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. GPCR signaling via cAMP nanodomains.The Biochemical journal · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Glucagon-like peptide 1 (GLP-1).Molecular metabolism · 2019 · on this map
    Review
  18. Article
  19. Article
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

M LiDepartment of Pharmacology, University of Colorado Health Sciences Center, and The Denver Veterans Affairs Medical Center, Denver, Colorado 80220, USA.
X Wang
M K Meintzer
T Laessig
M J Birnbaum
K A Heidenreich
University of Colorado Health · USUniversity of Pennsylvania · US

Funding

IMPROVING SURVIVAL OF TRANSPLANTED DOPAMINE NEURONSR01NS038619 · NINDS · UNIVERSITY OF COLORADO DENVER · PI HEIDENREICH, KIM A · 2000 to 2004
$940k
NINDS NIH HHS NS38619-01A1NINDS NIH HHS R01 NS038619
6 · The paper itself

Abstract

Agents that elevate intracellular cyclic AMP (cAMP) levels promote neuronal survival in a manner independent of neurotrophic factors. Inhibitors of phosphatidylinositol 3 kinase and dominant-inactive mutants of the protein kinase Akt do not block the survival effects of cAMP, suggesting that another signaling pathway is involved. In this report, we demonstrate that elevation of intracellular cAMP levels in rat cerebellar granule neurons leads to phosphorylation and inhibition of glycogen synthase kinase 3beta (GSK-3beta). The increased phosphorylation of GSK-3beta by protein kinase A (PKA) occurs at serine 9, the same site phosphorylated by Akt. Purified PKA is able to phosphorylate recombinant GSK-3beta in vitro. Inhibitors of GSK-3 block apoptosis in these neurons, and transfection of neurons with a GSK-3beta mutant that cannot be phosphorylated interferes with the prosurvival effects of cAMP. These data suggest that activated PKA directly phosphorylates GSK-3beta and inhibits its apoptotic activity in neurons.

Indexed as

Cell SurvivalPhosphorylationProto-Oncogene ProteinsSulfonamidesAnimalsApoptosisBrain ChemistryCalcium-Calmodulin-Dependent Protein KinasesCell FractionationCells, CulturedCerebellumColforsinCulture Media, Serum-FreeCyclic AMPEnzyme InhibitorsFlavonoids2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneAkt1 protein, ratCalcium-Calmodulin-Dependent Protein KinasesColforsinCulture Media, Serum-FreeCyclic AMPEnzyme InhibitorsFlavonoidsGlycogen Synthase Kinase 3Glycogen Synthase KinasesIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideProtein Kinase InhibitorsProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktRecombinant Fusion ProteinsSulfonamides

Identifiers

PMID11094086
PMCPMC102192
OpenAlexW2122807946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.